nifedipine has been researched along with gw9662 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Fukami, K; Matsui, T; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S | 2 |
Guo, F; Hashimoto, R; Itoh, S; Kishi, H; Kobayashi, S; Matsuzaki, M; Umeji, K; Umemoto, S | 1 |
5 other study(ies) available for nifedipine and gw9662
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Topics: Anilides; Calcium Channel Blockers; Chemokine CCL2; Cytoprotection; Glycation End Products, Advanced; Humans; Mesangial Cells; Nifedipine; PPAR gamma; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transcription, Genetic | 2009 |
Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP.
Topics: Anilides; Animals; Aorta; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Endothelium, Vascular; Hypertension; Immunoblotting; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Oxidative Stress; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Superoxide Dismutase; Superoxides | 2010 |
Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Topics: Anilides; Calcium Channel Blockers; Cells, Cultured; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Kidney Tubules; Nifedipine; Oxidative Stress; PPAR gamma; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2010 |